Christoph A Fux
Cohort-derived machine learning models for individual prediction of chronic kidney disease in people living with HIV: a prospective multicentre cohort study
Roth J, Bogojeska J, Bernasconi E, Kahlert C, Cavassini M, Calmy A, Scherrer A, Fux C, Kouyos R, Günthard H, Rauch A, Marzolini C, Radevski G, Battegay M. Cohort-derived machine learning models for individual prediction of chronic kidney disease in people living with HIV: a prospective multicentre cohort study. J Infect Dis 2020
09.05.2020Cohort-derived machine learning models for individual prediction of chronic kidney disease in people living with HIV: a prospective multicentre cohort study
09.05.2020J Infect Dis 2020
Roth Jan A, Bogojeska Jasmina, Bernasconi Enos, Kahlert Christian, Cavassini Matthias, Calmy Alexandra, Scherrer Alexandra U, Fux Christoph A, Kouyos Roger D, Günthard Huldrych F, Rauch Andri, Marzolini Catia, Radevski Gorjan, Battegay Manuel
Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study
Surial B, Wandeler G, Rauch A, Furrer H, Fux C, Schmid P, Bernasconi E, Stöckle M, Kovari H, Günthard H, Cavassini M, Calmy A, Ledergerber B, Swiss HIV Cohort Study. Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study. J Infect Dis 2020
19.03.2020Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study
19.03.2020J Infect Dis 2020
Surial Bernard, Wandeler Gilles, Rauch Andri, Furrer Hansjakob, Fux Christoph A, Schmid Patrick, Bernasconi Enos, Stöckle Marcel, Kovari Helen, Günthard Huldrych F, Cavassini Matthias, Calmy Alexandra, Ledergerber Bruno, Swiss HIV Cohort Study
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017
Ruffieux Y, Egger M, Keiser O, Vernazza P, Scherrer A, Marzolini C, Günthard H, Fux C, Cavassini M, Calmy A, Aebi-Popp K, Lemsalu L, Swiss HIV Cohort Study and the Swiss National Cohort. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017. J Int AIDS Soc 2019; 22:e25339.
01.08.2019Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017
01.08.2019J Int AIDS Soc 2019; 22:e25339
Ruffieux Yann, Egger Matthias, Keiser Olivia, Vernazza Pietro, Scherrer Alexandra, Marzolini Catia, Günthard Huldrych F, Fux Christoph A, Cavassini Matthias, Calmy Alexandra, Aebi-Popp Karoline, Lemsalu Liis, Swiss HIV Cohort Study and the Swiss National Cohort
Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study
Bayard C, Hasse B, Tarr P, Fux C, Di Benedetto C, Staehelin C, Weber R, Hoffmann M, Moulin E, Lecompte T, Flepp M, Ledergerber B, Swiss HIV Cohort Study. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study. Open Forum Infect Dis 2017; 4:ofx177.
22.08.2017Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study
22.08.2017Open Forum Infect Dis 2017; 4:ofx177
Bayard Cornelia, Hasse Barbara, Tarr Philip E, Fux Christoph A, Di Benedetto Caroline, Staehelin Cornelia, Weber Rainer, Hoffmann Matthias, Moulin Estelle, Lecompte Thanh, Flepp Markus, Ledergerber Bruno, Swiss HIV Cohort Study
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
Gueler A, Egger M, Zwahlen M, Vernazza P, Cavassini M, Battegay M, Fux C, Furrer H, Bernasconi E, Günthard H, Calmy A, Moser A. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS 2016
07.11.2016Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
07.11.2016AIDS 2016
Gueler Aysel, Egger Matthias, Zwahlen Marcel, Vernazza Pietro, Cavassini Matthias, Battegay Manuel, Fux Christoph A, Furrer Hansjakob, Bernasconi Enos, Günthard Huldrych F, Calmy Alexandra, Moser André
Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study
Conen A, Battegay M, Bucher H, Weber R, Vernazza P, Bernasconi E, Calmy A, Orasch C, Thurnheer M, Fux C, Glass T, Wang Q, Fehr J. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study. J Acquir Immune Defic Syndr 2013; 64:472-8.
15.12.2013Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study
15.12.2013J Acquir Immune Defic Syndr 2013; 64:472-8
Conen Anna, Battegay Manuel, Bucher Heiner C, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Calmy Alexandra, Orasch Christina, Thurnheer Maria C, Fux Christoph A, Glass Tracy R, Wang Qing, Fehr Jan
Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
Drozdov D, Buchkremer F, Litke A, Schuetz P, Huber A, Bürgi U, Fux C, Bock A, Müller B, Albrich W, Ottiger C, Reutlinger B, Thomer A, Meili M, Schwarz S, Kouegbe R, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Triple P study group. Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial. Trials 2013; 14:84.
22.03.2013Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial
22.03.2013Trials 2013; 14:84
Drozdov Daniel, Buchkremer Florian, Litke Alexander, Schuetz Philipp, Huber Andreas, Bürgi Ulrich, Fux Christoph A, Bock Andreas, Müller Beat, Albrich Werner, Ottiger Cornelia, Reutlinger Barbara, Thomer Anja, Meili Marc, Schwarz Stefanie, Kouegbe Rita Bossart, Regez Katharina, Guglielmetti Merih, Schild Ursula, Conca Antoinette, Schäfer Petra, Triple P study group
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
Du Pasquier R, Vernazza P, Cavassini M, Günthard H, Cusini A, Gutmann C, Fux C, Yerly S, Kalubi M, Jilek S, Swiss HIV Cohort Study. Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy. AIDS 2013; 27:203-10.
14.01.2013Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
14.01.2013AIDS 2013; 27:203-10
Du Pasquier Renaud A, Vernazza Pietro, Cavassini Matthias, Günthard Huldrych F, Cusini Alexia, Gutmann Christine, Fux Christoph A, Yerly Sabine, Kalubi Malela, Jilek Samantha, Swiss HIV Cohort Study
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
Cusini A, Günthard H, Opravil M, Gutmann C, Zenger F, Klimkait T, Cavassini M, Gaudenz R, Hirschel B, Widmer N, Rohrbach J, Fux C, Ledergerber B, Decosterd L, Yerly S, Vernazza P, Swiss HIV Cohort Study. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. J Acquir Immune Defic Syndr 2013; 62:28-35.
01.01.2013Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
01.01.2013J Acquir Immune Defic Syndr 2013; 62:28-35
Cusini Alexia, Günthard Huldyrich F, Opravil Milos, Gutmann Christine, Zenger Franziska, Klimkait Thomas, Cavassini Matthias, Gaudenz Roman, Hirschel Bernhard, Widmer Nicolas, Rohrbach Janine, Fux Christoph A, Ledergerber Bruno, Decosterd Laurent A, Yerly Sabine, Vernazza Pietro, Swiss HIV Cohort Study
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Young J, Bucher H, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Furrer H, Fux C, Schäfer J, the Swiss HIV Cohort Study. Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS 2012; 26:567-575.
13.03.2012Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
13.03.2012AIDS 2012; 26:567-575
Young Jim, Bucher Heiner C, Battegay Manuel, Weber Rainer, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Furrer Hansjakob, Fux Christoph A, Schäfer Juliane, the Swiss HIV Cohort Study
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Fehr J, Hirschel B, Vernazza P, Martinetti G, Bernasconi E, Günthard H, Battegay M, Bucher H, Klimkait T, Fux C, Cavassini M, Glass T, Louvel S, Hamy F, Hirsch H, von Wyl V, Böni J, Yerly S, Bürgisser P, Hiv Cohort Study A. Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. J Transl Med 2011; 9:14.
21.01.2011Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
21.01.2011J Transl Med 2011; 9:14
Fehr Jan, Hirschel Bernard, Vernazza Pietro, Martinetti Gladys, Bernasconi Enos, Günthard Huldrych F, Battegay Manuel, Bucher Heiner C, Klimkait Thomas, Fux Christoph A, Cavassini Matthias, Glass Tracy R, Louvel Severine, Hamy Francois, Hirsch Hans H, von Wyl Viktor, Böni Jürg, Yerly Sabine, Bürgisser Philippe, Hiv Cohort Study And The Swiss
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
Khanna N, Hirsch H, Battegay M, Bernasconi E, Vernazza P, Fux C, Cavassini M, Garzoni C, Mueller N, Elzi L, Swiss HIV Cohort Study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66.
15.05.2009Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
15.05.2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66
Khanna Nina, Hirsch Hans H, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Cavassini Matthias, Garzoni Christian, Mueller Nicolas J, Elzi Luigia, Swiss HIV Cohort Study
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
Khanna N, Hirsch H, Battegay M, Viscidi R, Bernasconi E, Vernazza P, Fux C, Du Pasquier R, Garzoni C, Mueller N, Wolbers M, Swiss HIV Cohort Study. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. Journal of virology 2009; 83:4404-11.
01.05.2009JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
01.05.2009Journal of virology 2009; 83:4404-11
Khanna Nina, Hirsch Hans H, Battegay Manuel, Viscidi Raphael, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Du Pasquier Renaud A, Garzoni Christian, Mueller Nicolas J, Wolbers Marcel, Swiss HIV Cohort Study
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Elzi L, Battegay M, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Fux C, Weber R, Kaufmann G, Swiss HIV Cohort Study. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV clinical trials 2009; 10:207-14.
01.01.2009Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
01.01.2009HIV clinical trials 2009; 10:207-14
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Fux Christoph A, Weber Rainer, Kaufmann Gilbert, Swiss HIV Cohort Study
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Young J, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Fux C, Rickenbach M, Guenthard H, Bucher H, Swiss HIV Cohort Study. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy 2009; 14:771-9.
01.01.2009Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
01.01.2009Antiviral therapy 2009; 14:771-9
Young Jim, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Fux Christoph A, Rickenbach Martin, Guenthard Huldrych F, Bucher Heiner C, Swiss HIV Cohort Study
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Simcock M, Rauch A, Swiss HIV Cohort Study. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy 2008; 13:1077-82.
01.01.2008Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
01.01.2008Antiviral therapy 2008; 13:1077-82
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Simcock Mathew, Rauch Andri, Swiss HIV Cohort Study
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Wolbers M, Simcock M, Swiss HIV Cohort Study. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antiviral therapy 2007; 12:1165-73.
01.01.2007Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
01.01.2007Antiviral therapy 2007; 12:1165-73
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Wolbers Marcel, Simcock Mathew, Swiss HIV Cohort Study
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Wunder D, Furrer H, Mueller B, Bernasconi E, Schmid P, Elzi L, Cavassini M, Hirschel B, Mueller N, Fux C, Bersinger N, Swiss HIV Cohort Study. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antiviral therapy 2007; 12:261-5.
01.01.2007Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
01.01.2007Antiviral therapy 2007; 12:261-5
Wunder Dorothea M, Furrer Hansjakob, Mueller Bruno, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Mueller Nicolas J, Fux Christoph A, Bersinger Nick A, Swiss HIV Cohort Study